Helsinki statement on human in vitro fertilization.

R. G. Edwards , M. SEPPäLä , W. I. H. Johnston , H. W. JonesJr
Annals of the New York Academy of Sciences 442 ( 1) 571 -572

2
1985
Pregnancy proteins in the endometrium after follicle aspiration for in vitro fertilization.

T. WAHLSTRÖM , A. I. KOSKIMIES , A. TENHUNEN , E.-M. RUTANEN
Annals of the New York Academy of Sciences 442 ( 1) 402 -407

21
1985
Diurnal variation of sex hormone binding globulin and insulin‐like growth factor binding protein‐1 in women with polycystic ovary syndrome

Diana Hamllton-Falrley , Davlnla White , Martin Griffiths , Victor Anyaoku
Clinical Endocrinology 43 ( 2) 159 -165

25
1995
Maternal plasma prolactin levels in preeclampsia.

H A Unnérus , U H Stenman , J Rossi , T Ranta
Obstetrics & Gynecology 55 ( 4) 428 -430

29
1980
Alpha-fetoprotein in Rh-immunized pregnancies.

E Ruoslahti , M Seppälä
Obstetrics & Gynecology 42 ( 5) 701 -706

27
1973
Monoclonal antibodies reacting with placental protein 5: use in radioimmunoassay, Western blot analysis, and immunohistochemistry.

U H Stenman , R Bützow , I Virtanen , O Närvänen
Journal of Laboratory and Clinical Medicine 111 ( 2) 249 -256

21
1988
Placental protein 5 (PP5)-like immunoreactivity in human urine.

H Bohn , J E Siiteri , M Seppälä , R Koistinen
Oncodevelopmental biology and medicine : the journal of the International Society for Oncodevelopmental Biology and Medicine 3 403 -407

1982
Multiple forms of messenger ribonucleic acid encoding glycodelin in male genital tract.

H Koistinen , J Salo , M Seppälä , R Koistinen
Laboratory Investigation 76 ( 5) 683 -690

41
1997
Distribution of serum transferrin groups in Finland and their inheritance.

M Seppälä
Annales medicinae experimentalis et biologiae Fenniae 43

12
1965
Assisted reproduction and risks of superovulation

K Teramo , K Raivio , M Seppälä , A Tiitinen
Duodecim lääketieteellinen aikakauskirja 112 ( 4) 245 -247

1996
[Alpha 1-fetoprotein in obstetrics].

M Seppälä
Duodecim lääketieteellinen aikakauskirja 89 ( 20) 1353 -1354

1973
Biologically active peptides

M Seppälä , J Leppäluoto , O Mäkelä
Duodecim lääketieteellinen aikakauskirja 92 ( 22) 1261 -1264

1976
Insulin-like growth factor-I (IGF-I) may not be essential for ovarian follicular development: evidence from IGF-I deficiency.

J Dor , I Ben-Shlomo , B Lunenfeld , C Pariente
The Journal of Clinical Endocrinology and Metabolism 74 ( 3) 539 -542

56
1992
Insulin-like Growth Factor-I and Follicle-Stimulating Hormone Suppress Insulin-like Growth Factor Binding Protein- 1 Secretion by Human Granulosa-Luteal Cells.

J Dor , N Costritsci , C Pariente , J Rabinovici
The Journal of Clinical Endocrinology and Metabolism 75 ( 3) 969 -971

22
1992
Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas.

J Tapper , R Bützow , T Wahlström , M Seppälä
British Journal of Cancer 75 ( 12) 1782 -1787

73
1997
13
1993
Tri-iodothyronine and cycloheximide enhance insulin-like growth factor-binding protein-1 gene expression in human hepatoma cells.

M Angervo , P Leinonen , R Koistinen , M Julkunen
Journal of Molecular Endocrinology 10 ( 1) 7 -13

29
1993
Advances in uterine protein research: reproduction and cancer

M Seppälä
International Journal of Gynecology & Obstetrics 85 ( 2) 105 -118

12
2004
FIGO's Constitution and Bye-Laws

M Seppälä
International Journal of Gynecology & Obstetrics 86 ( 2) 190 -201

2004
The role of FIGO in the advancement of women's health - in the year 2000.

M Seppälä
International Journal of Gynecology & Obstetrics 70 ( 1) 175 -182

1
2000